Subscribe to our Newsletters !!


    Nicoya gets NRC IRAP financing to create salivation based indicative test for COVID-19

    Nicoya, a main supplier of cutting edge expository instruments for the biotechnology and pharmaceutical businesses, will get warning administrations and up to $299,190 in innovative work subsidizing from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to build up a compact COVID-19 demonstrative test called Atlas. This financing comes as a

    Blend of nanotechnology and hereditary designing for managing lethal malignant growth stemness

    The development of chemotherapeutic agents with discerning anti-cancer actions is unattractive due to the emergence of resistance, inadequate targeting of cancer tissues, and subsequent metastasis. One of tumor attribute cellular types, cancer stem cells have become associated with cancer development and metastasis, representing self-renewal and their propensity to join the flow. Scientists at Japan Advanced

    BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research

    HEIDELBERG, Germany, November 09, 2020 / B3C newswire / — German independent research institute BioMed X adds a further research program in the field of immunology to their existing collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson: The new project will focus on the development of

    Inhalation Sciences signs IRS contract worth 584,000 SEK with leading nanotech company

    Inhalation Research Services, ISAB’s contract research organization, has signed a contract worth 584 000 SEK with a leading nanotechnology company that specializes in developing new inhalable nanoporous particles for drug delivery. The client has chosen ISAB’s unique intratracheal in vivo exposure module for its research project, due to its proven precision and reliability. The development